BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Study: mRNA Vaccines Perform Better Against COVID-19 Variants of Concern

  Scientists in New Zealand have found that mRNA-based COVID-19 vaccines produce greater antibody levels compared to adenovirus vector-based ones across major COVID-19 variants.

  May 18, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Axsome Takes New Approach, Targets NMDA Receptors With AXS-05 to Treat Depression

  Axsome Therapeutics announced that it published the results of its Ascend Phase-II clinical trial of AXS-05 to treat Major Depressive Disorder in The American Journal of Psychiatry.

  May 18, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  Hengrui Pharma Launches New Company to Make Medicine Accessible

  Hengrui Pharma is seeking to make medicines more available and affordable worldwide with the launch of Luzsana that opens up access to treatment for hundreds of illnesses.

  May 18, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Policy

  Greece Goes After Novartis for Alleged Bribery and Kickbacks

  Greece’s Health Minister Thanos Plevris announced plans to sue Novartis over what he alleges are illegal practices. In addition to demanding compensation, the country is implementing a three-point plan.

  May 18, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Money on the Move: SwanBio, Remix, Locus, Mirvie and More

  Recent funding saw support for a platform that selectively degrades DNA, software to help read mammograms and a company using corn genetics to develop cancer-targeting viruses.

  May 18, 2022

   · 

  8 min read

   · 

  Hannah Chudleigh
• 

  Researchers May Have Unlocked Mechanism Driving Inflammation in Rheumatoid Arthritis

  Researchers at Hokkaido University in Japan, in a collaboration with American scientists, may have unlocked the mechanism that drives widespread inflammation in inflammatory diseases.

  May 18, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Business

  Aquestive Therapeutics CEO Keith Kendall Departs After 20 Years

  The current president, CEO and board member, Keith Kendall, is departing Aquestive. He will be replaced by Daniel Barber, its current chief operating officer.

  May 18, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Industrializing Autologous Cell and Gene Therapy Manufacturing to Bring Quality Products to Patients

  Orgenesis is developing a point-of-care manufacturing platform for cell and gene and other advanced therapies to make them more widely available and significantly more affordable.

  May 18, 2022

   · 

  4 min read

   · 

  Gail Dutton
• 

  The Highest Paying Life Science Jobs in 2022

  BioSpace surveyed thousands of industry professionals to get the most current, accurate salary statistics. Read on to find out the top-paying jobs in each sector.

  May 18, 2022

   · 

  2 min read

   · 

  Rosemary Scott
• 

  Drug Development

  Capsida, Adverum, Instil and Metagenomi Showcase Therapies at ASGCT (Updated)

  The American Society of Gene and Cell Therapy annual meeting continues to see companies showcasing promising therapeutics for multiple disease indications.

  May 18, 2022

   · 

  4 min read

   · 

  Alex Keown